AC
PRME icon

AXQ Capital’s Prime Medicine PRME Stock Holding History

AXQ Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,742
Closed -$128K – 1270
2026
Q1 		$128K Buy
36,742
+3,337
+10% +$12.7K 0.02% 838
2025
Q4 		$116K Sell
33,405
-11,413
-25% -$50.8K 0.03% 637
2025
Q3 		$248K Buy
44,818
+7,231
+19% +$29.4K 0.1% 375
2025
Q2 		$92.8K Buy
+37,587
New +$57.9K 0.03% 523
2025
Q1 		– Sell
-15,363
Closed -$44.9K – 649
2024
Q4 		$44.9K Buy
+15,363
New +$53.9K 0.02% 403

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AXQ Capital's PRME Position: Q2 2026 in Review

AXQ Capital sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 36,742 shares — an estimated $128K sold.

AXQ Capital first reported a position in PRME in Q4 2024 and held it in 5 quarters. The position peaked at $248K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • AXQ Capital reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 36,742 Prime Medicine shares in Q2 2026, an estimated $128K.
  • AXQ Capital first reported a position in Prime Medicine in Q4 2024 and held it in 5 quarters.
  • AXQ Capital's Prime Medicine position peaked at $248K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.